In vitro and animal studies have demonstrated that intravitreal anti-VEGF upregulates the inflammation in the kidney and retina [17], but current real-world evidence regarding renal complications after intravitreal anti-VEGF treatments remains scarce, and only case reports have demonstrated a possible correlation between intravitreal anti-VEGFs and kidney injuries [18–24]. Here, VEGFA is linked to kidney injury.